<p>Performance of serum liver fibrosis indexes among different subgroups in the prediction of CSPH and SPH.</p
Hepatitis C can lead to liver fibrosis and cirrhosis. We compared readily available non-invasive fib...
<p>(A) The aspartate aminotransferase-platelet ratio index (APRI), (B) FIB-4 index, and (C) Forns in...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p
BACKGROUND/AIMS: The majority of non-invasive markers of liver fibrosis have been developed in patie...
Background: Chronic liver diseases (CLDs) generally progress from inflammation to fibrosis and final...
Background/Aims: chronic hepatitis C (CHC) is characterised by hepatic fibrosis, used as a proxy mea...
Background/Aims: The invasiveness of a liver biopsy and its inconsistent results have prompted effor...
<p>Diagnostic Accuracy of FibroTest for the Prediction of Significant Fibrosis and Cirrhosis in Vari...
Background. Only a few biomarkers based on metabolic parameters for evaluating liver fibrosis have b...
<p>Clinical parameters predictive of significant liver necroinflammation and fibrosis by multivariat...
<div><p>Latest data suggest that placental growth factor (PLGF), growth differentiation factor-15 (G...
Background: A great interest has been dedicated to the development of non invasive predictive models...
<p>Accuracy of AngioScore and other liver fibrosis indices in the total cohort of CHC patients.</p
Univariate analysis of the factors and liver fibrosis stages in the PNALT patients.</p
Liver fibrosis remains an important risk factor for hepatocarcinogenesis in patients with chronic he...
Hepatitis C can lead to liver fibrosis and cirrhosis. We compared readily available non-invasive fib...
<p>(A) The aspartate aminotransferase-platelet ratio index (APRI), (B) FIB-4 index, and (C) Forns in...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p
BACKGROUND/AIMS: The majority of non-invasive markers of liver fibrosis have been developed in patie...
Background: Chronic liver diseases (CLDs) generally progress from inflammation to fibrosis and final...
Background/Aims: chronic hepatitis C (CHC) is characterised by hepatic fibrosis, used as a proxy mea...
Background/Aims: The invasiveness of a liver biopsy and its inconsistent results have prompted effor...
<p>Diagnostic Accuracy of FibroTest for the Prediction of Significant Fibrosis and Cirrhosis in Vari...
Background. Only a few biomarkers based on metabolic parameters for evaluating liver fibrosis have b...
<p>Clinical parameters predictive of significant liver necroinflammation and fibrosis by multivariat...
<div><p>Latest data suggest that placental growth factor (PLGF), growth differentiation factor-15 (G...
Background: A great interest has been dedicated to the development of non invasive predictive models...
<p>Accuracy of AngioScore and other liver fibrosis indices in the total cohort of CHC patients.</p
Univariate analysis of the factors and liver fibrosis stages in the PNALT patients.</p
Liver fibrosis remains an important risk factor for hepatocarcinogenesis in patients with chronic he...
Hepatitis C can lead to liver fibrosis and cirrhosis. We compared readily available non-invasive fib...
<p>(A) The aspartate aminotransferase-platelet ratio index (APRI), (B) FIB-4 index, and (C) Forns in...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p
DOI
Add to ORKG